J. Frank Harmon
Plus aucun poste en cours
Profil
J.
Frank Harmon worked as Senior Vice President-Manufacturing Operations at Cardinal Health, Inc. from 2000 to 2006.
He then worked as Chief Operating Officer & Executive Vice President at APP Pharmaceuticals, Inc. and Fresenius Kabi Pharmaceuticals Holding LLC.
He also worked as Vice President-Biopharmaceutical Operations at Aventis Behring.
In 2006, he became Executive Vice President-Global Operations at Abraxis BioScience, Inc. and later became Chief Operating Officer & Executive Vice President at Abraxis Pharmaceutical Products.
From 2016 to 2018, he worked as Executive Vice President-Global Operations at Sagent Pharmaceuticals, Inc. Mr. Harmon holds an MBA from St. Louis University and an undergraduate degree from the University of Western Kentucky.
Anciens postes connus de J. Frank Harmon
| Sociétés | Poste | Fin |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | Directeur des opérations | 01/10/2018 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Directeur des opérations | 15/11/2007 |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/04/2006 |
Abraxis Pharmaceutical Products
 Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Directeur des opérations | - |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Directeur des opérations | - |
Formation de J. Frank Harmon
| St. Louis University | Masters Business Admin |
| University of Western Kentucky | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| Entreprise privées | 6 |
|---|---|
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
| Aventis Behring | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
Abraxis Pharmaceutical Products
Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
